I see some newfound discipline among Big Pharma in not chasing undifferentiated drugs that are a day late and a dollar short. MRK’s dropping Betrixaban is a case in point (#msg-61300408).
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”